Clinical Trial Update: Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1) [Phase 3]

View source ↗

Summary

This Phase 3 SURMOUNT-1 trial is evaluating the efficacy and safety of weekly tirzepatide versus placebo in adults who are obese or overweight with weight-relat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Hudson Biotech | Conditions: Obesity, Overweight (Without Type 2 Diabetes) With Weight-related Comorbidities | Phase 3 | Status: RECRUITING